Javier Goicolea

Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

Pascal Vranckx, Marco Valgimigli, Peter Jüni et al. · The Lancet · 2018 · 785 citations · Full text

Medicine, Cardiology, Pharmacotherapy +16

A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions

Gerald S. Werner, Victoria Martín‐Yuste, David Hildick‐Smith et al. · European Heart Journal · 2018 · 571 citations · Full text

Medicine, Cardiology, Internal Medicine +17

Randomized Comparison of Sirolimus-Eluting Stent Versus Standard Stent for Percutaneous Coronary Revascularization in Diabetic Patients

Manel Sabaté, Pilar Jiménez‐Quevedo, Dominick J. Angiolillo et al. · Circulation · 2005 · 367 citations · Full text

Medicine, Internal Medicine, Clinical Cardiology +13

Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study

Javier Escaned, Carlos Collet, Nicola Ryan et al. · European Heart Journal · 2017 · 295 citations · Full text

Medicine, Cardiology, Surgery +17

Comparison of a Novel Biodegradable Polymer Sirolimus-Eluting Stent With a Durable Polymer Everolimus-Eluting Stent

Stephan Windecker, Michael Haude, Franz‐Josef Neumann et al. · Circulation Cardiovascular Interventions · 2015 · 229 citations · Full text

Medicine, Pharmacotherapy, Biocompatibility +12